Joseph Seitlinger
Overview
Explore the profile of Joseph Seitlinger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
183
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Seitlinger J, Stasiak F, Piccoli J, Maffeis G, Streit A, Wollbrett C, et al.
Front Oncol
. 2023 Feb;
12:1078606.
PMID: 36776360
Introduction: The place of segmentectomy in the management of lung cancer is shifting following the inspiring results of the Japanese JCOG0802 trial. I n this study, authors suggested that performing...
12.
Stasiak F, Seitlinger J, Streit A, Wollbrett C, Piccoli J, Siat J, et al.
J Pers Med
. 2023 Jan;
13(1).
PMID: 36675751
Occult micrometastases can be missed by routine pathological analysis. Mapping of the pulmonary lymphatic system by near-infrared (NIR) fluorescence imaging can identify the first lymph node relay. This sentinel lymph...
13.
Le H, Seitlinger J, Lindner V, Olland A, Falcoz P, Benkirane-Jessel N, et al.
Biomedicines
. 2022 Jul;
10(7).
PMID: 35884982
Synthetic 3D multicellular systems derived from patient tumors, or tumoroids, have been developed to complete the cancer research arsenal and overcome the limits of current preclinical models. They aim to...
14.
Vascularization of Patient-Derived Tumoroid from Non-Small-Cell Lung Cancer and Its Microenvironment
Seitlinger J, Nounsi A, Idoux-Gillet Y, Santos Pujol E, Le H, Grandgirard E, et al.
Biomedicines
. 2022 May;
10(5).
PMID: 35625840
Patient-derived tumoroid (PDT) has been developed and used for anti-drug screening in the last decade. As compared to other existing drug screening models, a PDT-based in vitro 3D cell culture...
15.
Schmitt M, Aussenac L, Seitlinger J, Lindner V, Noel G, Antoni D
Cancers (Basel)
. 2022 Mar;
14(5).
PMID: 35267589
Background: Stereotactic radiotherapy for localised stage non-small-cell lung carcinoma (NSCLC) is an alternative indication for patients who are inoperable or refuse surgery. A study showed that the microscopic tumour extension...
16.
Seitlinger J, Prieto M, Guerrera F, Streit A, Gauchotte G, Siat J, et al.
Clin Lung Cancer
. 2021 Sep;
23(1):e29-e42.
PMID: 34583910
Background: We sought to evaluate prognostic value of neutrophil-to-lymphocyte ratio (NLR) in surgically resected non-small cell lung cancer (NSCLC) and its correlation to oncogenic drivers. We retrospectively reviewed data of...
17.
Seitlinger J, Prieto M, Siat J, Renaud S
J Thorac Dis
. 2021 May;
13(4):2636-2642.
PMID: 34012612
Renal cell carcinoma (RCC) remains a public health issue and seems to be increasing. A significant proportion of RCC patients will develop pulmonary metastasis at some point in their evolution....
18.
Seitlinger J, Wollbrett C, Mazzella A, Schmid S, Guerrera F, Banga Nkomo D, et al.
Ann Thorac Surg
. 2020 Dec;
112(6):1870-1876.
PMID: 33333085
Background: The coronavirus disease 2019 (COVID-19) pandemic has decreased surgical activity, particularly in the field of oncology, because of the suspicion of a higher risk of COVID-19-related severe events. This...
19.
Seitlinger J, Olland A, Guinard S, Massard G, Falcoz P
Interact Cardiovasc Thorac Surg
. 2020 Nov;
32(1):55-63.
PMID: 33236089
Objectives: Since video-assisted thoracic surgery (VATS) was first performed in the early 1990s, there have been many developments, and the conversion rate has decreased over the years. This article highlights...
20.
Seitlinger J, Banga Nkomo D, Streit A, Stasiak F, Renaud S
J Thorac Oncol
. 2020 Sep;
15(10):e172-e173.
PMID: 32981609
No abstract available.